Letters to the Editor
Retention and clinical response to abatacept in patients with rheumatoid arthritis: an Italian perspective
M. Galeazzi1, R. Alten2, M. Chartier3, Y. Elbez4, E. Fusaro5, M. Le Bars6, H.-M. Lorenz7, G. Pagano Mariano8, M. Muratore9, H.G. Nüßlein10, G. Patanè11
- University of Siena, Italy.
- Schlosspark-Klinik University of Medicine, Berlin, Germany.
- Bristol-Myers Squibb, Rueil-Malmaison, France.
- Excelya, Boulogne-Billancourt, France.
- A.O.U. Città della Salute e della Scienza di Torino, Italy.
- Bristol-Myers Squibb, Rueil-Malmaison, France.
- University Hospital, Heidelberg, Germany.
- Unit of Rheumatology, Azienda Ospedaliera Bianchi- Melacrino-Morelli, Reggio Calabria, Italy.
- Unità Operativa di Reumatologia, Presidio Ospedaliero Vito Fazzi, San Cesario di Lecce, Italy.
- University of Erlangen-Nuremberg, Nuremberg, Germany.
- Bristol-Myers Squibb, Rome, Italy. giovanni.patane@bms.com
CER10419
2018 Vol.36, N°5
PI 0935, PF 0936
Letters to the Editor
Free to view
(click on article PDF icon to read the article)
PMID: 29600933 [PubMed]
Received: 16/03/2017
Accepted : 11/09/2017
In Press: 21/03/2018
Published: 26/09/2018